OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (TORRENT PHARMACEUTICALS LIMITED)
Welcome to the PulseAid listing for the OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE drug offered from TORRENT PHARMACEUTICALS LIMITED. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | TORRENT PHARMACEUTICALS LIMITED |
NON-PROPRIETARY NAME: | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 20/12.5 |
SUBSTANCE NAME: | OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-04-24 |
END MARKETING DATE: | 0000-00-00 |
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE HUMAN PRESCRIPTION DRUG Details:
Item Description | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE from TORRENT PHARMACEUTICALS LIMITED |
LABELER NAME: | TORRENT PHARMACEUTICALS LIMITED |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20; 12.5(mg/1; mg/1) |
START MARKETING DATE: | 2017-04-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 13668-251_541fb57c-f4d8-4980-9994-86fe7ccec177 |
PRODUCT NDC: | 13668-251 |
APPLICATION NUMBER: | ANDA206515 |
Other OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers: